Vivos (RDGL) EPS (Weighted Average and Diluted) (2022 - 2025)
Vivos' (RDGL) quarterly EPS (Weighted Average and Diluted) came in at -$0.01 in Q4 2025, little changed year-on-year from -$0.01 in Q4 2024, and down 795.55% quarter-over-quarter from -$0.0 in Q3 2025.
Vivos (RDGL) EPS (Weighted Average and Diluted) (2022 - 2025) Analysis & Trends
Vivos has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting -$0.01 for Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.01, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.01 (changed 0.0% YoY), and the FY2025 annual result was -$0.01, changed 0.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.01 for Q4 2025 at Vivos, down from -$0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q1 2023 to a low of -$0.01 in Q4 2023.
- The 4-year median for EPS (Weighted Average and Diluted) is -$0.0 (2025), against an average of -$0.0.
- Across the five-year window, EPS (Weighted Average and Diluted) plunged 398.02% in 2023 and soared 49.09% in 2024, its largest moves.
- Vivos' EPS (Weighted Average and Diluted) stood at -$0.0 in 2022, then slumped by 398.02% to -$0.01 in 2023, then changed by 0.0% to -$0.01 in 2024, then changed by 0.0% to -$0.01 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.01 (Q4 2025), -$0.0 (Q3 2025), and -$0.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Vivos | - | - | -3,105.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |